SEATTLE — Moxifloxacin-loaded punctum plugs delivered and maintained moxifloxacin levels in the tear fluid above the minimum inhibitory concentration for common susceptible pathogens for 7 days after ...

A corticosteroid-loaded punctum plug significantly reduced inflammation and pain after cataract surgery, according to results of a phase 2 clinical trial. The hydrogel plug (dexamethasone, Ocular ...

The first tear duct implant developed to treat inflammation and pain following cataract surgery has been shown to be a reliable alternative to medicated eye drops, which are the current standard of ...

Punctal plugs effectively improve symptoms of dry eye disease, enhancing tear breakup time, tear production, and Ocular Surface Disease Index. The review included 17 studies with a high retention rate ...

Completion of Facility Enables Initiation of Phase 3 Clinical Trial of Nepafenac in Patients Undergoing Cataract Surgery AUSTIN, Texas, Sept. 12, 2023 /PRNewswire/ -- Mati Therapeutics Inc. ("Mati") ...

CHICAGO — A tapered-release dexamethasone punctum plug appears to be a reasonable alternative to medicated eye drops for patients who have undergone cataract surgery, according to early research. "In ...

A retrospective administrative claims analysis of treatment options for dry eye disease (DED) evaluated treatment patterns and utilization characteristics of patients receiving cyclosporine, punctal ...

This punctal plug prototype both blocks tear drainage and delivers dry-eye medication. Image courtesy of UNIVERSITY OF FLORIDA “It is estimated that 10–30% of people suffer from the condition known as ...

CHICAGO – Oct. 19, 2014 – The first tear duct implant developed to treat inflammation and pain following cataract surgery has been shown to be a reliable alternative to medicated eye drops, which are ...

AUSTIN, Texas, Sept. 12, 2023 /PRNewswire/ -- Mati Therapeutics Inc. ("Mati") announced that it has completed and now occupies a facility dedicated to manufacturing all products formulated in Mati's ...